Ọrịa Crohn (CD) bụ ọrịa na-adịghị ala ala nke na-anaghị akpata mbufụt eriri afọ. Isi ihe kpatara ọrịa Crohn ka edoghị anya, ugbu a, ọ gụnyere mkpụrụ ndụ ihe nketa, ọrịa, gburugburu ebe obibi na ihe ndị metụtara immunologic.

N'ime iri afọ ole na ole gara aga, ọrịa Crohn amụbaala nke ukwuu. Kemgbe e bipụtara mbipụta mbụ nke ntuziaka omume ahụ, ọtụtụ mgbanwe emeela na nchọpụta na ọgwụgwọ nke ndị ọrịa nwere ọrịa Crohn. Ya mere, na 2018, American Society of Gastroenterology emelitere ntuziaka nke Ọrịa Crohn ma tinye ụfọdụ aro maka nchọpụta na ọgwụgwọ, nke e mere iji dozie nsogbu ahụike metụtara ọrịa Crohn nke ọma. A na-atụ anya na dọkịta ga-enwe ike ijikọta ntuziaka na mkpa, ọchịchọ na ụkpụrụ onye ọrịa mgbe ọ na-eme mkpebi ahụike iji jikwaa ndị ọrịa nwere ọrịa Crohn nke ọma na nke ọma.

Dịka American Academy of Gastroenteropathy (ACG) si kwuo, "Fecal calprotectin(Cal) bụ ihe ngosi nnwale bara uru, ọ nwere ike inyere aka ịmata ọdịiche dị n'etiti ọrịa eriri afọ mkpali (IBD) na ọrịa eriri afọ iwe (IBS). Na mgbakwunye, ọtụtụ ọmụmụ egosila na "Fecal calprotectin" na-achọpụta IBD na kansa eriri afọ, mmetụta nke ịchọpụta IBD na IBS nwere ike iru 84%-96.6%, nkọwapụta ahụ nwere ike iru 83%-96.3%.

Mara ihe gbasara yaCalprotectin (Cal) nke na-emebi nsị.